Journal of Affective Disorders
Volume 122, Issue 1 , Pages 27-38 , April 2010

Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial

  • Roger S. McIntyre

      Affiliations

    • University of Toronto, Toronto, ON, Canada
    • Corresponding Author InformationCorresponding author. University of Toronto, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, Canada M5T 2S8. Tel.: +1 416 603 5279; fax: +1 416 603 5368.
    • ,
  • Miriam Cohen

      Affiliations

    • Merck, Summit, NJ, United States
    • ,
  • Jun Zhao

      Affiliations

    • Merck, Summit, NJ, United States
    • ,
  • Larry Alphs

      Affiliations

    • Employed at Pfizer Global Research and Development, Ann Arbor, MI, United States, at the time of this study
    • ,
  • Thomas A. Macek

      Affiliations

    • Employed at Pfizer Global Research and Development, Ann Arbor, MI, United States, at the time of this study
    • ,
  • John Panagides

      Affiliations

    • Merck, Summit, NJ, United States

Received 13 October 2009 ,Revised 15 December 2009 ,Accepted 29 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0165-0327(10)00007-8

doi: 10.1016/j.jad.2009.12.028

Journal of Affective Disorders
Volume 122, Issue 1 , Pages 27-38 , April 2010

Article Tools

* Image Usage & Resolution